BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7755153)

  • 1. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis.
    Sreenan JJ; Hart WR
    Am J Surg Pathol; 1995 Jun; 19(6):666-74. PubMed ID: 7755153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
    Costa MJ; Guinee D
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
    Costa MJ; Khan R; Judd R
    Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study.
    Abdulfatah E; Lordello L; Khurram M; Van de Vijver K; Alosh B; Bandyopadhyay S; Oliva E; Ali-Fehmi R
    Int J Gynecol Pathol; 2019 May; 38(3):205-215. PubMed ID: 30958427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypoid or non-polypoid? A novel dichotomous approach to uterine carcinosarcoma.
    Djordjevic B; Gien LT; Covens A; Malpica A; Khalifa MA
    Gynecol Oncol; 2009 Oct; 115(1):32-36. PubMed ID: 19640575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
    El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
    Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
    Tanimoto H; Shigemasa K; Sasaki M; Katayama H; Kusumi I; Parmley TH; O'Brien TJ; Ohama K
    Oncol Rep; 2000; 7(6):1209-12. PubMed ID: 11032915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary heterologous carcinosarcoma (metaplastic carcinoma) of the urinary bladder: a clinicopathologic, immunohistochemical, and ultrastructural analysis of eight cases and a review of the literature.
    Perret L; Chaubert P; Hessler D; Guillou L
    Cancer; 1998 Apr; 82(8):1535-49. PubMed ID: 9554532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.
    Matsuo K; Takazawa Y; Ross MS; Elishaev E; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Yanai S; Takeuchi S; Nishimura M; Iwasaki K; Johnson MS; Yoshida M; Hakam A; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Kajiwara H; Hasegawa K; Yasuda M; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Pejovic T; Nagano T; Sasaki T; Richmond AM; Post MD; Shahzad MMK; Im DD; Yoshida H; Enomoto T; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
    Ann Surg Oncol; 2018 Sep; 25(9):2756-2766. PubMed ID: 29971677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinosarcomas of the uterus and ovary: a clinicopathologic and immunohistochemical study of 11 cases.
    Kondi-Pafiti A; Grapsa D; Hasiakos D; Gennatas K; Fotiou S
    Eur J Gynaecol Oncol; 2009; 30(1):93-7. PubMed ID: 19317268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
    Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis shows that carcinosarcomas of the breast are of monoclonal origin.
    Teixeira MR; Qvist H; Bøhler PJ; Pandis N; Heim S
    Genes Chromosomes Cancer; 1998 Jun; 22(2):145-51. PubMed ID: 9598802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
    Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
    Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
    Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in carcinosarcomas of the uterus: differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements.
    Emoto M; Iwasaki H; Ishiguro M; Kikuchi M; Horiuchi S; Saito T; Tsukamoto N; Kawarabayashi T
    Hum Pathol; 1999 Oct; 30(10):1232-41. PubMed ID: 10534173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytodiagnostic problems in uterine sarcoma. Analysis according to a novel classification of tumor growth types.
    Oda K; Okada S; Nei T; Shirai T; Takahashi M; Sano Y; Shiromizu K
    Acta Cytol; 2004; 48(2):181-6. PubMed ID: 15085749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases.
    Silverberg SG; Major FJ; Blessing JA; Fetter B; Askin FB; Liao SY; Miller A
    Int J Gynecol Pathol; 1990; 9(1):1-19. PubMed ID: 2152890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.